ACS Medicinal Chemistry Letters · 2021 · 23 citations · 10 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyEnzyme InhibitionLigand BindingNanomedicineAdenylate Cyclase RegulationAdenylate Cyclase SignalingAdenylyl Cyclase SignalingEnzyme Inhibition ScreeningInhibitor ScreeningTherapeutic Target IdentificationTherapeutic Target Validation
Soluble adenylyl cyclase (sAC) has gained attention as a potential therapeutic target given the role of this enzyme in intracellular signaling. We describe successful efforts to design improved sAC inhibitors amenable for in vivo interrogation of sAC inhibition to assess its potential therapeutic applications. This work culminated in the identification of TDI-10229 (12), which displays nanomolar inhibition of sAC in both biochemical and cellular assays and exhibits mouse pharmacokinetic properties sufficient to warrant its use as an in vivo tool compound.
10
Lingle Wang, Yujie Wu, Yuqing Deng et al. · Journal of the American Chemical Society · 2015 · 1.4K citations · Full text